Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

DAWN

Day One Biopharmaceuticals Inc

Jan 16 • 04:00PM ET

10.16

-0.34 -3.24 %

Healthcare • Biotechnology • USA • NASD

Peers: VRTX NBIX BPMC SRPT EXEL FATE IGMS KURA BHVN PBYI

| Held by: XBI VTI IWM VB VXF IWN IBB VBR SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.49	Insider Own	28.27%	Shs Outstand	102.68M	Perf Week	13.65%
Market Cap	1.07B	Forward P/E	-	EPS next Y	-0.54	Insider Trans	-0.19%	Shs Float	75.82M	Perf Month	23.15%
Enterprise Value	625.27M	PEG	-	EPS next Q	-0.19	Inst Own	70.56%	Short Float	14.74%	Perf Quarter	36.01%
Income	-151.76M	P/S	8.03	EPS this Y	1.87%	Inst Trans	-0.01%	Short Ratio	4.20	Perf Half Y	58.75%
Sales	133.67M	P/B	2.31	EPS next Y	45.92%	ROA	-27.23%	Short Interest	11.18M	Perf YTD	9.01%
Book/sh	4.39	P/C	2.38	EPS next 5Y	-	ROE	-30.16%	52W High	13.53 -24.91%	Perf Year	-14.41%
Cash/sh	4.27	P/FCF	-	EPS past 3/5Y	28.09% -38.09%	ROIC	-33.46%	52W Low	5.64 80.30%	Perf 3Y	-55.79%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	89.44%	Volatility	9.23% 7.21%	Perf 5Y	-
Dividend TTM	-	EV/Sales	4.68	EPS Y/Y TTM	-46.75%	Oper. Margin	-123.90%	ATR (14)	0.76	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.55	Sales Y/Y TTM	31.11%	Profit Margin	-113.53%	RSI (14)	55.88	Recom	1.20
Dividend Gr. 3/5Y	- -	Current Ratio	8.68	EPS Q/Q	-149.93%	SMA20	5.57%	Beta	-1.27	Target Price	23.56
Payout	-	Debt/Eq	0.01	Sales Q/Q	-57.56%	SMA50	10.93%	Rel Volume	1.56	Prev Close	10.50
Employees	181	LT Debt/Eq	0.01	Earnings	Nov 04 AMC	SMA200	35.37%	Avg Volume	2.66M	Price	10.16
IPO	May 27, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	36.01% 5.21%	Trades		Volume	4,156,280	Change	-3.24%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-13-26	Resumed	TD Cowen	Buy	$34
Aug-19-25	Initiated	Piper Sandler	Overweight	$25
Oct-09-24	Reiterated	Needham	Buy	$32 → $33
Aug-01-24	Upgrade	BofA Securities	Underperform → Buy	$11 → $24
Apr-24-24	Reiterated	Needham	Buy	$30 → $33
Apr-25-23	Downgrade	BofA Securities	Buy → Underperform	$34 → $9
Feb-08-23	Initiated	CapitalOne	Overweight	$40
Feb-03-23	Initiated	Oppenheimer	Perform
Dec-15-22	Initiated	H.C. Wainwright	Buy	$35
Dec-14-22	Initiated	Needham	Buy	$40
Dec-05-22	Initiated	Goldman	Buy	$45
Dec-01-22	Initiated	BofA Securities	Buy	$34

Show Previous Ratings

Jan-15-26 09:55AM	Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 107.36%: Read This Before Placing a Bet (Zacks)
Jan-13-26 09:21AM	Day One Biopharmaceuticals (DAWN) Surges 26.7%: Is This an Indication of Further Gains? (Zacks) -6.53%
Jan-12-26 04:18PM	JPM Preannouncements: Why Alnylam And Sarepta Lost, But Day One Won (Investor's Business Daily) +26.73%
10:56AM	JPM Preannouncements Take Their Toll As Alnylam Slides, Tempus, Day One Pop (Investor's Business Daily)
Jan-11-26 05:00PM	Day One Announces Preliminary 2025 OJEMDA Net Product Revenue And Provides 2026 Net Product Revenue Guidance (GlobeNewswire)
05:00AM	Loading…
Jan-08-26 05:00AM	Day One concludes Mersana Therapeutics acquisition (Pharmaceutical Technology)
Jan-06-26 09:02AM	Day One Completes Acquisition of Mersana Therapeutics (GlobeNewswire)
Dec-16-25 08:30AM	Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-15-25 11:11PM	Day One Biopharma (DAWN) Announces Positive 3-Year Follow-up Results from Pivotal Phase 2 FIREFLY-1 Trial of OJEMDA (Tovorafenib) (Insider Monkey)
Dec-11-25 10:31AM	Xoma Crumbles And Partner Rezolute Collapses On Failed Insulin Disease Drug (Investor's Business Daily)
Nov-24-25 08:00AM	Day One Announces Three Year Follow-Up Data From OJEMDA (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting (GlobeNewswire)
Nov-18-25 08:30AM	Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-17-25 09:55AM	Wall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 161.36%: Here's is How to Trade (Zacks)
Nov-13-25 04:31PM	Mersana Therapeutics Catapults 200% On Day One Bio's Surprise Buyout (Investor's Business Daily) -14.41%
09:07AM	Mersana Catapults 200% On Day One Bio's Surprise Buyout (Investor's Business Daily)
06:59AM	Loading…
06:59AM	Day One snaps up ADC maker Mersana in backloaded buyout deal (BioPharma Dive)
06:00AM	Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases (GlobeNewswire)
Nov-10-25 07:00AM	Day One Announces New OJEMDA (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting (GlobeNewswire)
Nov-05-25 12:06AM	Day One Biopharmaceuticals Inc (DAWN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com) +25.21%
Nov-04-25 05:10PM	Day One Biopharmaceuticals, Inc. (DAWN) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Day One Reports Third Quarter 2025 Financial Results and Corporate Progress (GlobeNewswire)
Nov-03-25 07:53AM	Day One Biopharmaceuticals Inc (DAWN) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-30-25 09:55AM	Wall Street Analysts See a 234.66% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High? (Zacks)
Oct-21-25 08:30AM	Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025 (GlobeNewswire)
Oct-14-25 09:55AM	Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 241.59%: Read This Before Placing a Bet (Zacks)
Oct-06-25 09:40AM	Day One Biopharmaceuticals (DAWN) Moves 7.0% Higher: Will This Strength Last? (Zacks) -8.18%
Sep-16-25 08:01AM	Monte Rosa Therapeutics (GLUE) Soars 44.1%: Is Further Upside Left in the Stock? (Zacks)
Sep-08-25 12:30AM	Piper Sandler Starts Coverage on Day One (DAWN) with Overweight Rating (Insider Monkey)
Aug-19-25 12:10AM	H.C. Wainwright Reiterates 'Buy' Rating on Day One Biopharmaceuticals, Inc. (DAWN) (Insider Monkey)
Aug-13-25 07:30AM	XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements (GlobeNewswire)
03:31AM	Loading…
Aug-06-25 03:31AM	Day One Biopharmaceuticals Inc (DAWN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com) -15.70%
Aug-05-25 04:00PM	Day One Reports Second Quarter 2025 Financial Results and Corporate Progress (GlobeNewswire)
Aug-04-25 09:54AM	Earnings To Watch: Day One Biopharmaceuticals Inc (DAWN) Reports Q2 2025 Result (GuruFocus.com)
Jul-24-25 09:55AM	Wall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 303.46%: Here's is How to Trade (Zacks)
Jul-22-25 08:30AM	Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025 (GlobeNewswire)
Jun-10-25 08:30AM	Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development (GlobeNewswire)
May-13-25 10:47AM	Is Day One Biopharmaceuticals, Inc. (DAWN) the Best Low Priced Biotech Stock to Buy Now? (Insider Monkey)
May-09-25 07:54AM	Is Day One Biopharmaceuticals, Inc. (DAWN) the Low Risk High Reward Stock Set to Triple by 2030? (Insider Monkey)
May-07-25 11:09AM	Q1 2025 Day One Biopharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -9.87%
03:21AM	Day One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
May-06-25 05:25PM	Day One Biopharmaceuticals, Inc. (DAWN) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.55%
04:01PM	Day One Reports First Quarter 2025 Financial Results and Corporate Progress (GlobeNewswire)
May-05-25 10:00AM	Day One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Report Preview: What to Expect (GuruFocus.com) -5.67%
May-03-25 02:13AM	Q1 2025 American International Group Inc Earnings Call (Thomson Reuters StreetEvents)
Apr-23-25 02:58PM	TimesSquare U.S. Small Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-22-25 08:30AM	Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025 (GlobeNewswire)
Apr-10-25 11:51PM	Day One Biopharmaceuticals Pullback Is A Potential Buying Opportunity (Seeking Alpha) -7.02% +5.33%
Apr-09-25 09:44AM	Day One Biopharmaceuticals, Inc. (DAWN): Among Stocks Under $10 that Will Triple (Insider Monkey) +8.35%
Apr-08-25 12:24AM	XOMA Royalty Corporation's Preferreds Still Offer Attractive Yields With A Biotech Twist (Seeking Alpha)
Mar-20-25 01:00AM	EXCLUSIVE: Plant Medicine Brand Apothékary Is Taking Customers on a $10,000 Immersive Trip to Japan (WWD)
Mar-05-25 09:00AM	Day One Biopharmaceuticals, Inc. (DAWN): A Bull Case Theory (Insider Monkey) +12.79%
Feb-25-25 05:55PM	Day One Biopharmaceuticals, Inc. (DAWN) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -16.50%
04:05PM	Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress (GlobeNewswire)
01:36AM	Day One Biopharmaceuticals Inc (DAWN) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-13-25 09:55AM	Does Day One Biopharmaceuticals (DAWN) Have the Potential to Rally 193.16% as Wall Street Analysts Expect? (Zacks)
Feb-11-25 08:30AM	Day One to Report Fourth Quarter and Full-Year 2024 Financial Results Tuesday, February 25, 2025 (GlobeNewswire)
Jan-28-25 08:56AM	Trump pledged to bring down food prices on Day One. Instead, eggs are getting more expensive (CNN Business)
05:30AM	Trump said hed bring prices down on Day One. That hasnt happened (CNN Business)
Jan-23-25 01:02AM	Why Is Andreas Halvorsen Bullish On Day One Biopharmaceuticals, Inc. (DAWN) Now? (Insider Monkey)
Jan-22-25 08:44AM	New Tariffs Didnt Come on Trumps Day One. A Trade War May Not Be in the Wings. (Barrons.com)
Jan-20-25 03:31PM	President Trump outlines a frenzy of Day One executive orders and actions: Heres a list of what to expect (FastCompany)
Jan-13-25 08:00AM	Day One Reports Preliminary 2024 OJEMDA Net Product Revenue and Highlights 2025 Corporate Priorities (GlobeNewswire)
Dec-24-24 04:30PM	Are These AI Stocks Ready for a Comeback? (InvestorPlace)
Dec-22-24 03:30PM	Are These AI Stocks Ready for a Comeback? (InvestorPlace)
Dec-19-24 03:19PM	Are These AI Stocks Ready for a Comeback? (InvestorPlace)
Dec-17-24 08:30AM	Day One to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-16-24 09:49AM	How Trump Can Help Crypto on Day One (CoinDesk)
Dec-06-24 08:53PM	Instagram locks out developers of third-party consumer apps (TechCrunch)
Nov-27-24 10:18AM	Why Is Day One Biopharmaceuticals Inc. (DAWN) Among the Best Up and Coming Stocks to Buy According to Analysts? (Insider Monkey)
Nov-20-24 04:30PM	Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development (GlobeNewswire)
Nov-18-24 08:30AM	Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-06-24 09:55AM	Wall Street Analysts See a 136.83% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High? (Zacks)
Oct-30-24 05:20PM	Day One Biopharmaceuticals, Inc. (DAWN) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
04:01PM	Day One Reports Third Quarter 2024 Financial Results and Corporate Progress (GlobeNewswire)
Oct-21-24 09:55AM	Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 140.71%: Read This Before Placing a Bet (Zacks)
Oct-16-24 08:44AM	Day One Biopharmaceuticals (DAWN): Advancing Targeted Therapies for Pediatric Glioma (Insider Monkey)
08:30AM	Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024 (GlobeNewswire)
Oct-01-24 08:00PM	At What Oil Price Will Shale Drillers Stop Drilling? (Oilprice.com)
Aug-27-24 12:49PM	Taylor Fritzs Girlfriend Morgan Riddle Opts for Classic Little Black Dress on Day One of the U.S. Open 2024 (WWD)
Aug-19-24 11:15AM	Jeff Bezos Said 'I Predict One Day Amazon Will Fail' And Claims Large Companies Only Last '30-Plus Years' Guess How Old Amazon Is? (Benzinga)
Aug-14-24 11:46AM	Bank of America Says Buy These 3 Stocks for a Double-Digit Rally (InvestorPlace)
Jul-30-24 01:52PM	DAWN Stock Earnings: Day One Biopharmaceutical Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
08:40AM	Day One Biopharmaceuticals, Inc. (DAWN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Day One Reports Second Quarter 2024 Financial Results and Corporate Progress (GlobeNewswire)
07:00AM	Day One Announces Oversubscribed $175.0 Million Private Placement (GlobeNewswire)
Jul-25-24 11:53AM	Ipsen outlines $461m for ex-US rights to Day Ones glioma therapy (Pharmaceutical Technology)
12:58AM	Ipsen and Day One enter into exclusive ex-U.S. licensing agreement to commercialize tovorafenib for the most common childhood brain tumor (GlobeNewswire)
Jun-27-24 09:51AM	Lupita Nyongo Shimmers in Sequined Off-the-shoulder Prada Jumpsuit and Satin Miniskirt at A Quiet Place: Day One Premiere (WWD)
Jun-24-24 04:50PM	Lupita Nyongo Gives Power Suiting a Sensual Spin in Double-breasted Blazer and High-waisted Shorts for A Quiet Place: Day One Photo Call (WWD)
Jun-22-24 04:11AM	Insider Selling: Director Saira Ramasastry Sells Shares of Day One Biopharmaceuticals Inc (DAWN) (GuruFocus.com)
Jun-19-24 12:14PM	Day One targets the growing ADC market with MabCare acquisition (Pharmaceutical Technology)
10:29AM	Day One (DAWN) In-Licenses MabCare Cancer Candidate, Stock Up (Zacks)
Jun-18-24 08:30AM	Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers (GlobeNewswire) +11.31%
Jun-11-24 07:46AM	Exclusive: Day One Ventures closes its third fund at $150 million (Fortune)
May-30-24 08:30AM	Day One Announces Sale of Priority Review Voucher for $108 Million (GlobeNewswire)
May-07-24 09:25AM	HC Wainwright Adjusts Price Target on Day One Biopharmaceuticals to $40 From $50, Maintains Buy Rating (MT Newswires)
May-06-24 10:53PM	DAWN Stock Earnings: Day One Biopharmaceutical Misses EPS for Q1 2024 (InvestorPlace)
04:30PM	Day One Reports First Quarter 2024 Financial Results and Corporate Progress (GlobeNewswire)
03:22AM	Day One Biopharmaceuticals Insider Sold Shares Worth $1,081,191, According to a Recent SEC Filing (MT Newswires)
May-04-24 02:31AM	Insider Sale at Day One Biopharmaceuticals Inc (DAWN) (GuruFocus.com)

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dubow Adam	Gen Counsel & Secretary	Nov 17 '25	Sale	8.91	4,319	38,503	62,626	Nov 18 07:04 PM
York Charles N II	COO and CFO	Nov 17 '25	Sale	8.91	4,062	36,212	294,715	Nov 18 07:02 PM
Merendino Lauren	Chief Commercial Officer	Nov 17 '25	Sale	8.91	3,726	33,216	50,809	Nov 18 07:00 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Nov 17 '25	Sale	8.91	15,894	141,690	177,165	Nov 18 06:59 PM
CHARLES YORK	Officer	Nov 17 '25	Proposed Sale	8.91	4,062	36,211		Nov 17 04:12 PM
LAUREN MERENDINO	Officer	Nov 17 '25	Proposed Sale	8.91	3,726	33,216		Nov 17 04:12 PM
ADAM DUBOW	Officer	Nov 17 '25	Proposed Sale	8.91	4,319	38,502		Nov 17 04:11 PM
JEREMY BENDER	Officer	Nov 17 '25	Proposed Sale	8.91	15,894	141,689		Nov 17 04:09 PM
York Charles N II	COO and CFO	Aug 18 '25	Sale	6.77	4,106	27,786	278,000	Aug 19 07:40 PM
Dubow Adam	Gen Counsel & Secretary	Aug 18 '25	Sale	6.77	4,365	29,538	54,858	Aug 19 07:38 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Aug 18 '25	Sale	6.77	16,058	108,666	161,365	Aug 19 07:37 PM
Merendino Lauren	Chief Commercial Officer	Aug 18 '25	Sale	6.77	3,766	25,485	41,931	Aug 19 07:36 PM
JEREMY BENDER	Officer	Aug 18 '25	Proposed Sale	6.77	16,058	108,666		Aug 18 05:33 PM
Merendino Lauren	Chief Commercial Officer	May 16 '25	Sale	6.26	3,927	24,575	35,161	May 19 05:54 PM
Dubow Adam	GENERAL COUNSEL	May 16 '25	Sale	6.26	4,552	28,486	47,136	May 19 05:48 PM
York Charles N II	COO, CFO AND SECRETARY	May 16 '25	Sale	6.26	4,282	26,796	265,231	May 19 05:45 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	May 16 '25	Sale	6.26	13,964	87,385	145,737	May 19 05:44 PM
CHARLES YORK	Officer	May 16 '25	Proposed Sale	6.26	4,282	26,796		May 16 04:09 PM
LAUREN MERENDINO	Officer	May 16 '25	Proposed Sale	6.26	3,927	24,575		May 16 04:09 PM
ADAM DUBOW	Officer	May 16 '25	Proposed Sale	6.26	4,552	28,486		May 16 04:08 PM
JEREMY BENDER	Officer	May 16 '25	Proposed Sale	6.26	13,964	87,385		May 16 04:08 PM
York Charles N II	COO, CFO AND SECRETARY	Feb 18 '25	Sale	11.96	4,370	52,278	252,638	Feb 21 06:10 PM
Dubow Adam	GENERAL COUNSEL	Feb 18 '25	Sale	11.96	4,646	55,580	39,602	Feb 21 06:08 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Feb 18 '25	Sale	11.96	12,048	144,130	128,015	Feb 21 06:05 PM
ADAM DUBOW	Officer	Feb 18 '25	Proposed Sale	11.96	4,646	55,580		Feb 18 06:07 PM
CHARLES YORK	Officer	Feb 18 '25	Proposed Sale	11.96	4,370	52,278		Feb 18 06:04 PM
JEREMY BENDER	Officer	Feb 18 '25	Proposed Sale	11.96	12,048	144,129		Feb 18 06:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DAWN

Day One Biopharmaceuticals Inc

Upgrade your FINVIZ experience